ICM
VRNT

Invenomic Capital Management’s Verint Systems VRNT Stock Holding History

Invenomic Capital Management’s Portfolio VRNT Stock Details VRNT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-100,000
Closed -$2.02M – 172
2025
Q3 		$2.02M Sell
100,000
-966,142
-91% -$19.9M 0.1% 132
2025
Q2 		$21M Sell
1,066,142
-89,390
-8% -$1.56M 1.19% 26
2025
Q1 		$20.6M Buy
1,155,532
+621,707
+116% +$14.9M 1.04% 25
2024
Q4 		$14.7M Buy
+533,825
New +$13.3M 0.7% 42

Other funds holding VRNT

DekaBank Deutsche Girozentrale
DekaBank Deutsche Girozentrale Frankfurt, Germany $59.2B AUM 26.02% 1-Year Est. Return
PCM
Palouse Capital Management Spokane, Washington $160M AUM 36.15% 1-Year Est. Return
IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return
HNB
Huntington National Bank Columbus, Ohio $18.1B AUM 24.69% 1-Year Est. Return

Invenomic Capital Management's VRNT Position: Q4 2025 in Review

Invenomic Capital Management sold out of Verint Systems (VRNT) in Q4 2025, closing a stake of 100,000 shares — an estimated $2.02M sold.

Invenomic Capital Management first reported a position in VRNT in Q4 2024 and held it in 4 quarters. The position peaked at $21M in Q2 2025. 4 funds tracked by Wall St. Rank hold VRNT as of Q4 2025.

  • Invenomic Capital Management reported no remaining Verint Systems position as of Q4 2025 after selling out during the quarter.
  • Invenomic Capital Management sold 100,000 Verint Systems shares in Q4 2025, an estimated $2.02M.
  • Invenomic Capital Management first reported a position in Verint Systems in Q4 2024 and held it in 4 quarters.
  • Invenomic Capital Management's Verint Systems position peaked at $21M in Q2 2025.
  • 4 funds tracked by Wall St. Rank held Verint Systems as of Q4 2025.

Based on Invenomic Capital Management's 13F filing for Q4 2025, filed 17 Feb 2026.